Search - tctmd.com

Displaying 281 - 300 of 310

Sort: Relevancy | Date

Presentation ACC 2012

Drug-Eluting Balloons: Novel Technology and Applications

Presenter: Sigmund Silber

March 26, 2012

News Daily News

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

Jason Kahn

March 22, 2012

News Daily News

Pulmonary Vein Stenting in Children Temporarily Improves Stenosis But Not Prognosis

March 21, 2012

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

March 06, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Industry News

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

February 01, 2012

News Industry News

Eurocor announces treatment of First Patients in International Randomized Freeride Study

January 24, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Industry News

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

November 10, 2011

News Industry News

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

November 09, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Conference News

DEB Promising in Critical Limb Ischemia, Femoropopliteal Arterial Disease

November 08, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

November 03, 2011

News Daily News

Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease

Jason Kahn

September 15, 2011

News Daily News

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Jason Kahn

September 08, 2011

Advertisement

Drug-Eluting Balloons: Novel Technology and Applications

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

Pulmonary Vein Stenting in Children Temporarily Improves Stenosis But Not Prognosis

SES Effective for Both Focal, Diffuse DES Restenosis

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Eurocor announces first insights of the Freeway Stent Study at LINC Congress

Eurocor announces treatment of First Patients in International Randomized Freeride Study

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

DEB Promising in Critical Limb Ischemia, Femoropopliteal Arterial Disease

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content